acetaminophen has been researched along with oridonin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, GH; Chen, SX; Diao, J; Gao, L; Hong, MK; Jia, H; Li, J; Liu, HH; Zhang, DD; Zhao, D; Zheng, SY; Zhu, JQ | 1 |
| Chen, M; Guo, D; Li, J; Wang, Y; Yu, D; Zhang, X; Zhou, Z | 1 |
2 other study(ies) available for acetaminophen and oridonin
| Article | Year |
|---|---|
Oridonin Alters Hepatic Urea Cycle via Gut Microbiota and Protects against Acetaminophen-Induced Liver Injury.
Topics: Acetaminophen; Animals; Bacteroides; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Diterpenes, Kaurane; Dysbiosis; Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Liver; Male; Metabolome; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2; Urea | 2021 |
Oridonin ameliorates acetaminophen-induced acute liver injury through ATF4/PGC-1α pathway.
Topics: Acetaminophen; Activating Transcription Factor 4; Chemical and Drug Induced Liver Injury; Humans; Liver; Molecular Docking Simulation; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2023 |